Groowe Groowe / Newsroom / NVS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVS News

Novartis AG

Amplifica Appoints Hans Hofland, Ph.D., as Chief Development Officer and William Humphries to Board of Directors

prnewswire.com
ACRS ALC AMGN BCRX BIIB BMY CRSP CTRA CYTK DASH EXAS GILD GSK INCY JNJ KDP LULU MRNA NBIX NVS OCGN ORCL PFE REGN ROST RVMD SNOW SRPT STRL TGTX TMO TRMB TSLA TXG VRTX XOM ZBRA

Global Neurodiagnostics Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight

globenewswire.com
ABBV AMRN AXSM BMY BIIB BSX LLY GSK JNJ MDT NVS NVO SNPS SUPN TMO ABT XOM

Global Antiparasitic Drugs (2026-2031) - Rising Prevalence of Parasitic Infections Drives Market Growth

globenewswire.com
JNJ MRK NVS PFE SNY TMO

Global Pediatric Drugs (2026-2031) - Rising Prevalence of Childhood Diseases Drives Market Growth

globenewswire.com
PFE JNJ GSK SNY NVS PTC BMRN JAZZ GILD LLY AMGN AZN MRK ABBV TAK

Ankylosing Spondylitis Treatment (2026-2031) - Rising Disease Prevalence and Biologic Therapy Adoption Drive Market Growth

globenewswire.com
ABBV NVS AMGN PFE LLY JNJ MRK GILD SNY TAK

Liposome Drug Delivery (2026-2031) - Growing Demand for Targeted Drug Delivery Drives Market Growth

globenewswire.com
GILD PCAR JNJ TEVA NVS PFE MRK

Global Immunomodulators 2026-2031 - Rising Prevalence of Autoimmune Diseases Drives Market Growth

globenewswire.com
BMY NVS MRK AMGN PFE LLY BIIB AZN GILD ABBV TMO REGN IMUX

Pulmonary Edema (2026-2031) - Rising Prevalence of Cardiovascular Diseases Drives Market Growth

globenewswire.com
ABBV AZN BSX BMY EL LLY JNJ MRK NVS PFE SNY VTRS

Upper Respiratory Tract Infection Treatment (2026-2031) - Rising Prevalence of Respiratory Infections Drives Market Growth

globenewswire.com
ABT ABBV ALC AZN BMY CI DDS JNJ MRK NVS PFE SNY TEVA VTRS

AI Disrupts Topical Drug Delivery as Billion-Dollar Partnerships and $3.3 Billion in VC Funding Signal a Structural Shift in Pharmaceutical Formulation

globenewswire.com
LLY RXRX NVDA NVS SNY SPRY